Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.3466
-0.0755 (-17.89%)
At close: Jul 2, 2026, 4:00 PM EDT
0.3667
+0.0201 (5.80%)
After-hours: Jul 2, 2026, 7:49 PM EDT
Curis Employees
As of December 31, 2025, Curis had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 10 or -29.41% compared to the previous year.
Employees
24
Change (1Y)
-10
Growth (1Y)
-29.41%
Revenue / Employee
$294,292
Profits / Employee
-$881,875
Market Cap
13.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | -10 | -29.41% | 20 | 4 |
| Dec 31, 2024 | 34 | -15 | -30.61% | 33 | 1 |
| Dec 31, 2023 | 49 | -2 | -3.92% | 49 | 0 |
| Dec 31, 2022 | 51 | -9 | -15.00% | 51 | 0 |
| Dec 31, 2021 | 60 | 32 | 114.29% | 60 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Quince Therapeutics | 38 |
| Citius Pharmaceuticals | 23 |
| CalciMedica | 16 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| BioVie | 13 |
| Tempest Therapeutics | 5 |
CRIS News
- 1 day ago - Curis trading halted, news pending - TheFly
- 8 days ago - Curis announces eleven active clinical sites in TakeAim CLL study - TheFly
- 8 days ago - Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split - PRNewsWire
- 9 days ago - Curis Transcript: EGM 2026 - Transcripts
- 4 weeks ago - Curis Proxy statement: Proxy filing - Filings
- 4 weeks ago - Curis Slides: Corporate presentation - Filings
- 6 weeks ago - Curis Proxy statement: Proxy filing - Filings
- 6 weeks ago - Curis Transcript: AGM 2026 - Transcripts